NCT01598441View on ClinicalTrials.gov

Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Pulmonary Hypertension
Interventions
DRUG

iloprost nebuliser solution

Iloprost nebuliser solution 500 ng/kg inhaled(10 min recommended) q3h for 2 days

DRUG

distilled water

1-2 ml aerosolized distilled water inhalation per session

Trial Locations (3)

200127

Cardiac intensive Care Unit,Department of Thoracic and Cardiovascular Sugery,Shanghai Children's Medical Center, Shanghai

430022

Wuhan Asia Hear Hospital, Wuhan

510000

Guangzhou Children's Hospital, Guangzhou

All Listed Sponsors
collaborator

Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery

UNKNOWN

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01598441 - Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD) | Biotech Hunter | Biotech Hunter